RecallRadar

FDA Drug recall D-1583-2014

0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-0049-03

On 2014-09-17 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-0049-03 by Baxter Healthcare, citing lack of Assurance of Sterility; complaints of mold in the overpouch.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1583-2014
ClassificationClass II
Statusterminated
Initiated2014-07-30
Published2014-09-17
Last updated2026-09-13 11:51 UTC
CompanyBaxter Healthcare
DistributionUS

Product

0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-0049-03

Reason

Lack of Assurance of Sterility; complaints of mold in the overpouch

Identifiers

ndc0338-0049-01
ndc0338-0049-02
ndc0338-0049-03
ndc0338-0049-04
ndc0338-0049-10
ndc0338-0049-41
ndc0338-0049-11
ndc0338-0049-31
ndc0338-0049-48
ndc0338-0049-18
ndc0338-0049-38
ndc0338-0043-03
ndc0338-0043-04
code_infoLot #C926642, Product Code: 2B1323N

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1583-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.